Verastem Stock (VSTM)

Track Verastem stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

At close
$6.87
â–¼ -0.54 (-7.29%)
Nov 18, 4:00 PM ET
After-hours
$6.90
â–² +0.03 (+0.44%)
Nov 18, 6:33 PM ET
$4.00$6.00$8.00$10Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26
Market Cap
$933.77M
P/E Ratio
—
1Y Return
-19.02%
EPS (TTM)
-$1.85

Read the latest TheStreet Pro articles mentioning Verastem, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

1 article

Daily Diary Mentions

1 mention
  • Select Premarket Movers

    Upside – $LQDA +41.0% ($380.7M global settlement resolves six lawsuits and preserves uninterrupted YUTREPIA commercialization) – $TCRT +25.5% (completed Velaris acquisition and secured an approximately $350M private placement to fund development through 2029) – $VSTM +11.0% (VS-7375 produced a 50% confirmed response rate in eight second-line pancreatic-cancer patients, with FDA alignment on a Phase 3 …

    Read in context ›